A Portable Nebulizer Option for Patients With COPD
Pharmacy Times,
This article was sponsored by Sunovion Pharmaceuticals Inc. Education and training on proper inhalation device technique is…
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
Benzinga,
- LONHALA MAGNAIR is the first nebulized long-acting muscarinic antagonist (LAMA) approved for the treatment of COPD in the U.S.
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
Business Wire,
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S.
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD - Press Release
Digital Journal,
MARLBOROUGH, Mass.--(Business Wire)-- Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S.
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
Minyanville: Finance ,
Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved the New Drug…